UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Epigenomics, ISSN 1750-1911, 06/2015, Volume 7, Issue 3, pp. 333 - 335
miRNA | PDAC | miR-21 | invasion | MMP9 | miR-211 | Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Pancreatic Neoplasms - metabolism | Neoplasm Invasiveness | Humans | Pancreatic Neoplasms - pathology | Carcinoma, Pancreatic Ductal - metabolism | Gene Expression Regulation, Neoplastic | Pancreatic Neoplasms - enzymology | MicroRNAs - metabolism | Pancreatic Neoplasms - genetics | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - genetics | Carcinoma, Pancreatic Ductal - enzymology | Gene Expression Regulation, Enzymologic | Matrix Metalloproteinase 9 - metabolism | Matrix Metalloproteinase 9 - genetics
Journal Article
Surgical endoscopy, ISSN 0930-2794, 1/2019, Volume 33, Issue 1, pp. 234 - 242
Sample size calculation | Gynecology | Propensity score | Medicine & Public Health | Robotic pancreatoduodenectomy | Surgery | Hepatology | Pancreatic cancer | Gastroenterology | Abdominal Surgery | Tumor margins | Proctology | Pancreatoduodenectomy | Life Sciences & Biomedicine | Science & Technology | Robotic Surgical Procedures - methods | Survival Rate - trends | Follow-Up Studies | Humans | Middle Aged | Pancreatic Neoplasms - surgery | Margins of Excision | Male | Postoperative Complications - epidemiology | Case-Control Studies | Incidence | Pancreaticoduodenectomy - methods | Propensity Score | Female | Italy - epidemiology | Aged | Pancreatic Neoplasms - mortality | Retrospective Studies | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 06/2009, Volume 27, Issue 16, pp. 2622 - 2629
Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | Medical sciences | Tumors | Immunohistochemistry | Predictive Value of Tests | ras Proteins - genetics | Phosphorylation | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | PTEN Phosphohydrolase - analysis | Drug Resistance, Neoplasm | Male | Patient Selection | Antibodies, Monoclonal, Humanized | Antineoplastic Agents, Phytogenic - administration & dosage | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Retrospective Studies | Cetuximab | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Colorectal Neoplasms - enzymology | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Treatment Outcome | Receptor, Epidermal Growth Factor - analysis | Protein Kinase Inhibitors - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins c-akt - analysis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Colorectal Neoplasms - secondary | Italy - epidemiology | Aged | Mutation | Longitudinal Studies | Index Medicus
Journal Article
Nature communications, ISSN 2041-1723, 2018, Volume 9, Issue 1, pp. 1845 - 18
a_open_article_in_open_journal | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | RNA-Binding Proteins - genetics | Up-Regulation | MicroRNAs - antagonists & inhibitors | Humans | Transforming Growth Factor beta1 - metabolism | Gene Expression Regulation, Neoplastic | MicroRNAs - metabolism | Carcinoma, Pancreatic Ductal - genetics | Female | Datasets as Topic | Introns - genetics | Pancreatic Neoplasms - pathology | Carcinogenesis - genetics | Pancreas - pathology | Pancreatic Neoplasms - genetics | Signal Transduction - genetics | Carcinoma, Pancreatic Ductal - pathology | Disease Progression | Xenograft Model Antitumor Assays | Animals | Mice, Nude | Cell Line, Tumor | Mice | MicroRNAs - genetics | RNA-Binding Proteins - metabolism | RNA, Small Interfering - metabolism | Adenocarcinoma | Deactivation | Mesenchyme | Transcription | p53 Protein | Cell junctions | Inactivation | Argonaute 2 protein | Ribonucleic acid--RNA | Coding | Smad2 protein | miRNA | Activin | Pancreas | Index Medicus
Journal Article
Nature genetics, ISSN 1061-4036, 2015, Volume 47, Issue 8, pp. 911 - 916
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Genetic Predisposition to Disease - genetics | Europe | Gene Frequency | Humans | Middle Aged | Risk Factors | Genetic Loci - genetics | Genotype | Male | Pancreatic Neoplasms - genetics | North America | Chromosomes, Human, Pair 17 - genetics | Chromosomes, Human, Pair 2 - genetics | Female | Aged | Polymorphism, Single Nucleotide | Australia | Chromosomes, Human, Pair 7 - genetics | Genome-Wide Association Study - methods | Chromosomes, Human, Pair 3 - genetics | Genetic susceptibility | Genetic variation | Pancreatic cancer | Oncology, Experimental | Genetic research | Genetic aspects | Research | Identification and classification | Health aspects | Risk factors | Cancer | Genetics | Mutation | Genes | Index Medicus
Journal Article
6.
Full Text
FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer
World journal of gastroenterology : WJG, ISSN 1007-9327, 2016, Volume 22, Issue 31, pp. 6987 - 7005
treatments;MicroR | cancer | therapy;New | NA;Pancreatic | FOLFIRINOX;Personalized | FOLFIRINOX | MicroRNA | Personalized therapy | Pancreatic cancer | New treatments | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Leucovorin - administration & dosage | ErbB Receptors - antagonists & inhibitors | Humans | Translational Medical Research | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Pancreatic Neoplasms - drug therapy | Irinotecan | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Oxaliplatin | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Camptothecin - administration & dosage | Pancreatic Neoplasms - mortality | Camptothecin - analogs & derivatives | Precision Medicine | Index Medicus | Review
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 04/2006, Volume 66, Issue 7, pp. 3928 - 3935
Oncology | Cancer Research | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | 5'-Nucleotidase - genetics | Predictive Value of Tests | Pancreatic Neoplasms - metabolism | Prognosis | Humans | Middle Aged | Transcriptional Activation | Male | Pancreatic Neoplasms - drug therapy | Cytidine Deaminase - biosynthesis | Deoxycytidine - therapeutic use | Tumor Suppressor Proteins - genetics | Aged, 80 and over | Adult | Female | Deoxycytidine Kinase - genetics | 5'-Nucleotidase - biosynthesis | Gene Expression | Cytidine Deaminase - genetics | Equilibrative Nucleoside Transporter 1 - biosynthesis | Equilibrative Nucleoside Transporter 1 - genetics | Pancreatic Neoplasms - genetics | Ribonucleoside Diphosphate Reductase - genetics | Treatment Outcome | Reverse Transcriptase Polymerase Chain Reaction | Deoxycytidine Kinase - biosynthesis | Cell Line, Tumor | Aged | Ribonucleoside Diphosphate Reductase - biosynthesis | Tumor Suppressor Proteins - biosynthesis | Deoxycytidine - analogs & derivatives | Index Medicus
Journal Article
Current drug targets, ISSN 1389-4501, 01/2014, Volume 15, Issue 14, pp. 1331 - 1340
Tubulin | Synergistic interaction | Migration | c-Met | Malignant pleural mesothelioma | Pemetrexed | Tivantinib | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Proto-Oncogene Proteins c-met - metabolism | Guanine - analogs & derivatives | Humans | Lung Neoplasms - metabolism | Quinolines - pharmacology | Pleural Neoplasms - metabolism | Microtubules - metabolism | Guanine - pharmacology | Pyrrolidinones - pharmacology | Antineoplastic Agents - pharmacology | Drug Evaluation, Preclinical | Pleural Neoplasms - pathology | Lung Neoplasms - genetics | Mesothelioma - genetics | Thymidylate Synthase - genetics | Proto-Oncogene Proteins c-met - genetics | Drug Synergism | Cell Movement - drug effects | Mesothelioma - metabolism | Glutamates - pharmacology | Cell Line, Tumor | Cell Proliferation - drug effects | Mesothelioma, Malignant | Apoptosis
Journal Article
Nature genetics, ISSN 1061-4036, 2014, Volume 46, Issue 9, pp. 994 - 1000
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease | Humans | Middle Aged | Genotype | Male | Pancreatic Neoplasms - genetics | Genetic Loci | Case-Control Studies | Polymorphism, Single Nucleotide - genetics | Female | Aged | Genome-Wide Association Study - methods | Studies | Proteins | Medical research | Pancreatic cancer | Cell cycle | Genomes | Mutation | Pancreas | Epidemiology | Cell adhesion & migration | Index Medicus
Journal Article